Eli Lilly Corp. buy The Goldman Sachs Group, Inc.
Start price
04.02.26
/
50%
€912.10
Target price
04.02.27
-
Performance (%)
-13.65%
Price
17.04.26
€787.60
Summary
This prediction is currently active. The prediction for Eli Lilly Corp. disappoints with a performance of -13.65%. This prediction currently runs until 04.02.27. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | -1.685% | -1.685% |
| iShares Core DAX® | 3,59 % | 3,93 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % |
| iShares S&P 500 | 4,14 % | 4,04 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE:LLY) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Ratings data for LLY provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€881.10
13.12.25
13.12.25
€975.54
13.12.26
13.12.26
-10.61%
17.04.26
17.04.26
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€678.00
08.04.25
08.04.25
€810.30
08.04.26
08.04.26
20.34%
09.04.26
09.04.26